Showing results (41-50 of 214) with videos related to
Sort By:
Pageof 22
Journal of Occupational and Environmental Medicine|December 29, 2010
Prevalence rates and costs of metabolic syndrome and associated risk factors using employees' integrated laboratory data and health care claimsHoward G Birnbaum, Miles E Mattson, Sara Kashima, et al.Neurology|June 6, 2008
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosisG Birnbaum, B Cree, I Altafullah, et al.Federation Proceedings|August 1, 1978
Lymphocyte transformation induced by autologous cellsM E Weksler, M M Kuntz, G Birnbaum, et al.Pharmacoeconomics|March 3, 2012
Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006Howard G Birnbaum, Crystal Pike, Ritesh Banerjee, et al.Neurology|November 1, 1994
Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study GroupC Smith, G Birnbaum, J L Carter, et al.Hippocampus|March 20, 2015
CA1-specific deletion of NMDA receptors induces abnormal renewal of a learned fear responseSilke J Hirsch, Nanda L Regmi, Shari G Birnbaum, et al.Toxicology|May 1, 1988
Vagal tone monitoring: a potential indicator of anti-cholinesterase exposure in Macaca mulattaJ A Dellinger, H T Jansen, D J Zaber, et al.The Journal of Clinical Psychiatry|May 21, 2003
The economic burden of depression with painful symptomsPaul E Greenberg, Stephanie A Leong, Howard G Birnbaum, et al.Journal of Occupational and Environmental Medicine|September 12, 2008
Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United StatesAlan G White, Howard G Birnbaum, Carmela Janagap, et al.Journal of Occupational and Environmental Medicine|February 24, 2001
Impact of illness and its treatment on workplace costs: regulatory and measurement issuesP E Greenberg, H G Birnbaum, R C Kessler, et al.Pageof 22